Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1-Reference-Cited by-同舟云学术

Reduced Rate of Disease Development After HIV-2 Infection as Compared to HIV-1

Published:1994-09-09 Issue:5178 Volume:265 Page:1587-1590
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Marlink Richard¹,Kanki Phyllis¹,Thior Ibou²³,Travers Karin¹,Eisen Geoffrey¹,Siby Tidiane²,Traore Ibrahima²³,Hsieh Chung-Cheng⁴,Dia Mamadou Ciré²,Gueye El-Hadji²,Hellinger James¹,Guèye-Ndiaye Aissatou²,Sankalé Jean-Louis²,Ndoye Ibrahima³,Mboup Souleymane²,Essex Max¹

Affiliation:

1. Department of Cancer Biology, Harvard School of Public Health, Boston, MA02115, USA.

2. Laboratory of Virology and Bacteriology, University Cheikh Anta Diop, Dakar, Senegal.

3. Institute of Social Hygiene, Dakar, Senegal.

4. Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference42 articles.

1. Morbidity and Mortality Weekly Report 35 20: 334 (1986).

2. Morbidity and Mortality Weekly Report 36 1: S1 (1987).

3. WKLY EPIDEMIOL REC 65: 281 (1990).

4. ANDREASSON, P.A., A PROSPECTIVE-STUDY OF VERTICAL TRANSMISSION OF HIV-2 IN BISSAU, GUINEA-BISSAU, AIDS 7: 989 (1993).

5. BARIN, F, SEROLOGICAL EVIDENCE FOR VIRUS RELATED TO SIMIAN T-LYMPHOTROPIC RETROVIRUS III IN RESIDENTS OF WEST-AFRICA, LANCET 2: 1387 (1985).

Cited by 507 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status of the small molecule anti-HIV drugs in the pipeline or recently approved;Bioorganic & Medicinal Chemistry;2024-09

2. Epidemic characteristics of local HIV-2 transmission across Hunan province, China;Virus Research;2024-07

3. West African pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2;2024-05-22

4. Clinical Outcomes of Integrase Strand Transfer Inhibitors Containing Antiretroviral Therapy in HIV-2: A Narrative Review;Infectious Diseases and Therapy;2024-05-09

5. Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level;Pathogens;2024-04-24